Tag: Therapeutics Goods Administration
Australia to purchase 51 million doses of COVID-19 vaccine from Novavax
American vaccine development company Novavax, Inc. has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, its...
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
